577
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease

, , , , , , & show all
Pages 366-372 | Received 14 Dec 2009, Accepted 09 Mar 2010, Published online: 28 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shigehiro Karashima, Takashi Yoneda, Mitsuhiro Kometani, Masashi Ohe, Shunsuke Mori, Toshitaka Sawamura, Kenji Furukawa, Masakazu Yamagishi & Yoshiyu Takeda. (2016) Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus. Clinical and Experimental Hypertension 38:7, pages 565-570.
Read now
Jin Oshikawa, Yoshiyuki Toya, Satoshi Morita, Masataka Taguri, Kazushige Hanaoka, Toshio Hasegawa, Kazo Kaizu, Kouju Kamata, Shuzo Kobayashi, Takayasu Ohtake, Takeo Sato, Gen Yasuda, Kenjiro Kimura & Satoshi Umemura. (2014) Angiotensin receptor blocker (ARB)–diuretic versus ARB–calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy. Clinical and Experimental Hypertension 36:4, pages 244-250.
Read now

Articles from other publishers (8)

Shih-Yi Lin, Cheng-Li Lin, Cheng-Chieh Lin, Wu-Huei Hsu, Chung-Y. Hsu & Chia-Hung Kao. (2022) Chronic Kidney Disease Progression Risk in Patients With Diabetes Mellitus Using Dihydropyridine Calcium Channel Blockers: A Nationwide, Population-Based, Propensity Score Matching Cohort Study. Frontiers in Pharmacology 13.
Crossref
Arthur Greenberg. 2020. Chronic Renal Disease. Chronic Renal Disease 1053 1070 .
Eunsol Yang, Soyoung Lee, Heechan Lee, Inyoung Hwang, In-Jin Jang, Kyung-Sang Yu & SeungHwan Lee. (2019) Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects. Translational and Clinical Pharmacology 27:4, pages 134.
Crossref
Punnaka Pongpanich, Pasvich Pitakpaiboonkul, Kullaya Takkavatakarn, Kearkiat Praditpornsilpa, Somchai Eiam-Ong & Paweena Susantitaphong. (2018) The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis. International Urology and Nephrology 50:12, pages 2261-2278.
Crossref
Yiming Cheng, Rongshuang Huang, Sehee Kim, Yuliang Zhao, Yi Li & Ping Fu. (2016) Renoprotective effects of renin–angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients. Medicine 95:28, pages e4167.
Crossref
Shu Inami, Toru Kato, Shigeru Toyoda, Teruo Inoue, Kinji Tsukada, Akiya Nakamoto, Yoshinobu Kikegawa, Akihiro Suzuki, Yukitaka Anraku & Koichi Node. (2015) Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake. The American Journal of the Medical Sciences 350:3, pages 160-166.
Crossref
. (2012) Current World Literature. Current Opinion in Nephrology & Hypertension 21:5, pages 557-566.
Crossref
Toshihiko Ishimitsu. (2011) Antihypertensive Therapy Considering the Prevention of Vascular Aging. Journal of the Korean Society of Hypertension 17:3, pages 85.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.